IFM Investors Pty Ltd Acquires 3,942 Shares of Stryker Corporation $SYK

Key Points

• IFM Investors Pty Ltd increased its holdings in Stryker Corporation by 6.0%, owning a total of 69,457 shares valued at approximately $27.5 million.
• Stryker's recent quarterly earnings reported an EPS of $3.13, exceeding analyst expectations, and the company set its fiscal year 2025 guidance between $13.400 and $13.600 EPS.
• The company announced a quarterly dividend of $0.84 to be paid on October 31st, with an annualized yield of 0.9% and a payout ratio of 44.5%.

IFM Investors Pty Ltd increased its holdings in Stryker Corporation (NYSE:SYK - Free Report) by 6.0% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 69,457 shares of the medical technology company's stock after buying an additional 3,942 shares during the period. IFM Investors Pty Ltd's holdings in Stryker were worth $27,479,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Capital A Wealth Management LLC purchased a new stake in Stryker during the fourth quarter valued at about $26,000. Goodman Advisory Group LLC bought a new position in shares of Stryker during the first quarter valued at about $32,000. City Holding Co. grew its stake in shares of Stryker by 528.6% in the first quarter. City Holding Co. now owns 88 shares of the medical technology company's stock worth $33,000 after purchasing an additional 74 shares during the last quarter. Ransom Advisory Ltd bought a new stake in shares of Stryker in the first quarter worth about $37,000. Finally, Smallwood Wealth Investment Management LLC bought a new stake in shares of Stryker in the first quarter worth about $40,000. Hedge funds and other institutional investors own 77.09% of the company's stock.

Analyst Ratings Changes

SYK has been the topic of several research reports. Redburn Partners set a $420.00 price objective on Stryker in a research report on Thursday. Needham & Company LLC upped their price objective on Stryker from $442.00 to $448.00 and gave the company a "buy" rating in a research report on Friday, August 1st. BTIG Research reaffirmed a "buy" rating on shares of Stryker in a research report on Monday, July 14th. Evercore ISI increased their price target on Stryker from $390.00 to $415.00 and gave the company an "outperform" rating in a report on Tuesday, July 8th. Finally, Rothschild & Co Redburn started coverage on shares of Stryker in a report on Thursday. They issued a "neutral" rating and a $420.00 target price for the company. Fourteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $430.33.

Insider Activity at Stryker

In other news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the completion of the sale, the director owned 3,222,108 shares of the company's stock, valued at approximately $1,212,962,556.60. The trade was a 5.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Viju Menon sold 500 shares of Stryker stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $390.61, for a total transaction of $195,305.00. Following the sale, the insider directly owned 12,511 shares of the company's stock, valued at $4,886,921.71. This represents a 3.84% decrease in their position. The disclosure for this sale can be found here. Insiders own 5.90% of the company's stock.

Stryker Price Performance

Shares of NYSE SYK traded down $1.23 during mid-day trading on Friday, hitting $376.61. 1,924,253 shares of the company's stock traded hands, compared to its average volume of 934,259. The company has a market capitalization of $143.98 billion, a P/E ratio of 49.88, a PEG ratio of 2.71 and a beta of 0.93. Stryker Corporation has a 1 year low of $329.16 and a 1 year high of $406.19. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.06. The company's 50-day moving average is $387.52 and its two-hundred day moving average is $379.07.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.13 EPS for the quarter, topping the consensus estimate of $3.07 by $0.06. The company had revenue of $6.02 billion during the quarter, compared to analyst estimates of $5.92 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The firm's revenue was up 11.1% on a year-over-year basis. During the same quarter last year, the business posted $2.81 earnings per share. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. On average, equities analysts anticipate that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a $0.84 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.36 annualized dividend and a yield of 0.9%. Stryker's dividend payout ratio (DPR) is presently 44.50%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.